<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Titratable Medications Reference Table - Adventist Health</title>
    <style>
        /* Adventist Health Brand Styles */
        body {
            font-family: Arial, Helvetica, sans-serif;
            margin: 0;
            padding: 20px;
            background-color: #EFEFF0; /* AH Pastel Gray */
            font-size: 11px;
            line-height: 1.5;
        }
        
        .header {
            background-color: #003764; /* AH Dark Blue */
            color: white;
            padding: 20px;
            text-align: center;
            margin: -20px -20px 20px -20px;
            border-bottom: 4px solid #00A0DD; /* AH Light Blue accent */
        }
        
        h1 {
            color: white;
            margin: 0;
            font-size: 28px;
            font-weight: 600;
            letter-spacing: 0.5px;
        }
        
        .subtitle {
            color: #00A0DD; /* AH Light Blue */
            font-size: 14px;
            margin-top: 8px;
            font-weight: 400;
        }
        
        .table-container {
            overflow-x: auto;
            background: white;
            padding: 20px;
            border-radius: 4px;
            box-shadow: 0 2px 8px rgba(0, 55, 100, 0.1);
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin-bottom: 30px;
        }
        
        th {
            background-color: #003764; /* AH Dark Blue */
            color: white;
            padding: 14px 10px;
            text-align: left;
            font-weight: 600;
            font-size: 11px;
            border: 1px solid #00A0DD; /* AH Light Blue */
            position: sticky;
            top: 0;
            z-index: 10;
            letter-spacing: 0.3px;
        }
        
        td {
            padding: 12px 10px;
            border: 1px solid #D6EEF0; /* AH Pastel Teal */
            vertical-align: top;
            font-size: 10px;
            line-height: 1.5;
            color: #55565A; /* AH Gray */
        }
        
        tr:nth-child(even) {
            background-color: #E1F0FB; /* AH Pastel Blue */
        }
        
        tr:hover {
            background-color: #D6EEF0; /* AH Pastel Teal */
        }
        
        .medication-name {
            font-weight: bold;
            color: #003764; /* AH Dark Blue */
            font-size: 11px;
        }
        
        .high-alert {
            background-color: #FDDDD7; /* AH Pastel Pink */
            border-left: 4px solid #F8485E; /* AH Coral */
        }
        
        .non-formulary {
            background-color: #FFE5C2; /* AH Pastel Orange */
            font-style: italic;
            border-left: 4px solid #E24301; /* AH Orange */
        }
        
        .warning {
            color: #F8485E; /* AH Coral */
            font-weight: 600;
        }
        
        .concentration {
            white-space: pre-wrap;
            min-width: 100px;
        }
        
        .goal-param {
            white-space: pre-wrap;
            min-width: 120px;
        }
        
        .dosing {
            white-space: pre-wrap;
        }
        
        .comments {
            max-width: 400px;
            font-size: 9px;
            line-height: 1.4;
            color: #55565A; /* AH Gray */
        }
        
        /* Medication Category Colors - Using AH Accessibility Palette */
        .neuromuscular-blocker {
            background-color: #FDDDD7; /* AH Pastel Pink */
        }
        
        .sedative {
            background-color: #E0DEF0; /* AH Pastel Purple */
        }
        
        .vasopressor {
            background-color: #F0F7E8; /* AH Pastel Green */
        }
        
        .antihypertensive {
            background-color: #E1F0FB; /* AH Pastel Blue */
        }
        
        .analgesic {
            background-color: #FFFCDF; /* AH Pastel Yellow */
        }
        
        .inotrope {
            background-color: #D6EEF0; /* AH Pastel Teal */
        }
        
        .footer {
            text-align: center;
            margin-top: 30px;
            padding: 20px;
            color: #55565A; /* AH Gray */
            font-size: 10px;
            border-top: 2px solid #00A0DD; /* AH Light Blue */
        }
        
        @media print {
            body {
                background-color: white;
            }
            .header {
                margin: 0;
                page-break-after: avoid;
            }
            .table-container {
                box-shadow: none;
            }
            tr {
                page-break-inside: avoid;
            }
        }
        
        @media (max-width: 768px) {
            body {
                padding: 10px;
            }
            .header {
                margin: -10px -10px 10px -10px;
                padding: 15px;
            }
            h1 {
                font-size: 20px;
            }
            .subtitle {
                font-size: 12px;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>Titratable Medications Reference Table</h1>
        <div class="subtitle">Adventist Health Medication Safety Standards</div>
    </div>
    
    <div class="table-container">
        <table>
            <thead>
                <tr>
                    <th>Medication</th>
                    <th>Standard Concentration</th>
                    <th>Standard Dilution</th>
                    <th>Goal Parameter</th>
                    <th>Loading/Bolus Dose</th>
                    <th>Initial Rate</th>
                    <th>Increment Change</th>
                    <th>Frequency</th>
                    <th>Maximum Dose</th>
                    <th>Dosing Range</th>
                    <th>Order Comments</th>
                </tr>
            </thead>
            <tbody>
                <!-- Atracurium -->
                <tr class="neuromuscular-blocker high-alert">
                    <td class="medication-name">Atracurium<br><span class="warning">**HIGH ALERT**</span></td>
                    <td class="concentration">#1: 0.5 mg/mL<br>#2: 0.2 mg/mL</td>
                    <td class="dosing">#1: 50 mg/100 mL</td>
                    <td class="goal-param">• TOF 2/4<br>• Ventilator synchrony<br>• Other</td>
                    <td class="dosing">• 0.5 mg/kg<br>• Other</td>
                    <td>2 mcg/kg/min</td>
                    <td>1 mcg/kg/min</td>
                    <td>15 min</td>
                    <td>15 mcg/kg/min</td>
                    <td class="dosing">1 - 15 mcg/kg/min</td>
                    <td class="comments"><span class="warning">Warning: Paralyzing agent causes respiratory depression.</span> Patient must be ventilated and sedated prior to administration with RASS goal -4. Do not titrate sedation off while on paralytic.<br><br>Obtain baseline train-of-four prior to beginning infusion.<br><br>Goal parameter must be monitored and documented every 15 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Cisatracurium -->
                <tr class="neuromuscular-blocker high-alert">
                    <td class="medication-name">Cisatracurium<br><span class="warning">**HIGH ALERT**</span></td>
                    <td class="concentration">#1: 2 mg/mL</td>
                    <td class="dosing">#1: 200 mg/100 mL</td>
                    <td class="goal-param">• TOF 2/4<br>• Ventilator synchrony<br>• Other</td>
                    <td class="dosing">• 0.2 mg/kg<br>• Other</td>
                    <td>1 mcg/kg/min</td>
                    <td>1 mcg/kg/min</td>
                    <td>15 min</td>
                    <td>10 mcg/kg/min</td>
                    <td class="dosing">1 - 10 mcg/kg/min</td>
                    <td class="comments"><span class="warning">Warning: Paralyzing agent causes respiratory depression.</span> Patient must be ventilated and sedated prior to administration with RASS goal -4. Do not titrate sedation off while on paralytic.<br><br>Obtain baseline train-of-four prior to beginning infusion.<br><br>Goal parameter must be monitored and documented every 15 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Clevidipine -->
                <tr class="antihypertensive non-formulary">
                    <td class="medication-name">Clevidipine<br><span style="color: #E24301;">(AH non-formulary)</span></td>
                    <td class="concentration">#1: 0.5 mg/mL</td>
                    <td class="dosing">#1: 50 mg/100 mL<br>#2: 25 mg/50 mL</td>
                    <td class="goal-param">• SBP 130-150<br>• SBP 130-160<br>• SBP 140-180<br>• SBP 150-180, DBP <105<br>• SBP 150-185, DBP <110<br>• SBP 160-200<br>• Other</td>
                    <td>None</td>
                    <td>1 mg/hr</td>
                    <td>2 mg/hr</td>
                    <td>2 min</td>
                    <td>21 mg/hr</td>
                    <td class="dosing">1 - 21 mg/hr</td>
                    <td class="comments">Change vial and tubing every 12 hours.<br><br>Goal parameter must be monitored and documented every 2 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Dexmedetomidine -->
                <tr class="sedative">
                    <td class="medication-name">Dexmedetomidine</td>
                    <td class="concentration">#1: 4 mcg/mL</td>
                    <td class="dosing">#1: 400 mcg/100 mL<br>#2: 200 mcg/50 mL</td>
                    <td class="goal-param">• RASS 0 to -2</td>
                    <td>None</td>
                    <td>0.5 mcg/kg/hr</td>
                    <td>0.1 mcg/kg/hr</td>
                    <td>10 min</td>
                    <td>1.4 mcg/kg/hr</td>
                    <td class="dosing">0.1 - 1.4 mcg/kg/hr</td>
                    <td class="comments">Not appropriate alone if patient on neuromuscular blocker (NMB).<br><br>Goal parameter must be monitored and documented every 10 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>If HR less than 60, decrease rate by half & notify provider. If HR ≤ 50, pause the infusion & notify provider.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Diltiazem -->
                <tr class="antihypertensive">
                    <td class="medication-name">Diltiazem</td>
                    <td class="concentration">#1: 1 mg/mL</td>
                    <td class="dosing">#1: 125 mg/125 mL<br>#2: 100 mg/100 mL</td>
                    <td class="goal-param">• HR 60-110<br>• Other</td>
                    <td class="dosing">• 10 mg<br>• 20 mg<br>• Other</td>
                    <td>5 mg/hr</td>
                    <td>2.5 mg/hr</td>
                    <td>15 min</td>
                    <td>15 mg/hr</td>
                    <td class="dosing">2.5 - 15 mg/hr</td>
                    <td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Turn IV off 2 hours after oral meds given.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Dobutamine -->
                <tr class="inotrope">
                    <td class="medication-name">Dobutamine</td>
                    <td class="concentration">#1: 4000 mcg/mL<br>#2: 2000 mcg/mL</td>
                    <td class="dosing">#1: 1000 mg/250 mL<br>#2: 500 mg/250 mL</td>
                    <td class="goal-param">• MAP 65-75<br>• ScVO2 >70%<br>• CI 2-4<br>• Other</td>
                    <td>None</td>
                    <td>2.5 mcg/kg/min</td>
                    <td>2.5 mcg/kg/min</td>
                    <td>5 min</td>
                    <td>20 mcg/kg/min</td>
                    <td class="dosing">0.5 - 20 mcg/kg/min</td>
                    <td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Hold if HR >140.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Dopamine -->
                <tr class="vasopressor">
                    <td class="medication-name">Dopamine</td>
                    <td class="concentration">#1: 3200 mcg/mL<br>#2: 1600 mcg/mL</td>
                    <td class="dosing">#1: 800 mg/250 mL<br>#2: 400 mg/250 mL</td>
                    <td class="goal-param">• MAP 65-75<br>• Other</td>
                    <td>None</td>
                    <td>2 mcg/kg/min</td>
                    <td>2 mcg/kg/min</td>
                    <td>2 min</td>
                    <td>20 mcg/kg/min</td>
                    <td class="dosing">2 - 20 mcg/kg/min</td>
                    <td class="comments">Administration via peripheral line may be considered for up to 24 hours.<br><br>Rates greater than 10 mcg/kg/min must be administered via a central line.<br><br>Goal parameter must be monitored and documented every 2 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Hold if HR >140.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Epinephrine -->
                <tr class="vasopressor">
                    <td class="medication-name">Epinephrine</td>
                    <td class="concentration">#1: 20 mcg/mL<br>#2: 40 mcg/mL</td>
                    <td class="dosing">#1: 2 mg/100 mL<br>#2: 5 mg/250 mL<br>#3: 10 mg/250 mL</td>
                    <td class="goal-param">• MAP 65-75<br>• Other</td>
                    <td>None</td>
                    <td>1 mcg/min</td>
                    <td>1 mcg/min</td>
                    <td>2 min</td>
                    <td>20 mcg/min</td>
                    <td class="dosing">1 - 20 mcg/min</td>
                    <td class="comments">Administration via peripheral line may be considered for up to 24 hours.<br><br>Rates greater than 15 mcg/min must be administered via a central line.<br><br>Goal parameter must be monitored and documented every 2 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Hold if HR >140.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Esmolol -->
                <tr class="antihypertensive">
                    <td class="medication-name">Esmolol</td>
                    <td class="concentration">#1: 10 mg/mL<br>#2: 20 mg/mL</td>
                    <td class="dosing">#1: 2500 mg/250 mL<br>#2: 2000 mg/100 mL</td>
                    <td class="goal-param">• SBP 100-140<br>• SBP 130-160<br>• SBP 140-180<br>• HR 60-110<br>• Other</td>
                    <td class="dosing">• 500 mcg/kg<br>• 1000 mcg/kg<br>• Other</td>
                    <td>50 mcg/kg/min</td>
                    <td>50 mcg/kg/min</td>
                    <td>5 min</td>
                    <td>300 mcg/kg/min</td>
                    <td class="dosing">50 - 300 mcg/kg/min</td>
                    <td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Fentanyl -->
                <tr class="analgesic">
                    <td class="medication-name">Fentanyl</td>
                    <td class="concentration">#1: 10 mcg/mL<br>#2: 50 mcg/mL</td>
                    <td class="dosing">#1: 2500 mcg/250 mL<br>1000 mcg/100 mL<br>#2: 5000 mcg/100 mL<br>500 mcg/50 mL</td>
                    <td class="goal-param">• CPOT 0-2<br>• Other</td>
                    <td class="dosing">• 25 mcg<br>• 50 mcg<br>• 100 mcg<br>• Other</td>
                    <td>50 mcg/hr</td>
                    <td>25 mcg/hr</td>
                    <td>60 min</td>
                    <td>200 mcg/hr</td>
                    <td class="dosing">25 - 200 mcg/hr</td>
                    <td class="comments"><span class="warning">Warning: Medication causes respiratory depression.</span><br><br>For Breakthrough Pain (CPOT >2): Bolus 50 mcg every 5 minutes up to 3 times within one hour. If goal is not achieved after 3 consecutive boluses, then increase infusion rate.<br><br>Goal parameter must be monitored and documented every 60 minutes until goal is met.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Hydromorphone -->
                <tr class="analgesic">
                    <td class="medication-name">Hydromorphone</td>
                    <td class="concentration">#1: 0.2 mg/mL<br>#2: 1 mg/mL</td>
                    <td class="dosing">#1: 20 mg/100 mL<br>10 mg/50 mL<br>#2: 50 mg/50 mL</td>
                    <td class="goal-param">• CPOT 0-2<br>• Other</td>
                    <td class="dosing">• 0.2 mg<br>• 0.4 mg<br>• Other</td>
                    <td>0.5 mg/hr</td>
                    <td>0.2 mg/hr</td>
                    <td>60 min</td>
                    <td>2 mg/hr</td>
                    <td class="dosing">0.2 - 2 mg/hr</td>
                    <td class="comments"><span class="warning">Warning: Medication causes respiratory depression.</span><br><br>For Breakthrough Pain (CPOT >2): Bolus 0.4 mg every 10 minutes up to 3 times within one hour. If goal is not achieved after 3 consecutive boluses, then increase infusion rate.<br><br>Goal parameter must be monitored and documented every 60 minutes until goal is met.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Ketamine -->
                <tr class="analgesic">
                    <td class="medication-name">Ketamine</td>
                    <td class="concentration">#1: 10 mg/mL</td>
                    <td class="dosing">#1: 1000 mg/100 mL<br>#2: 500 mg/50 mL</td>
                    <td class="goal-param">• CPOT 0-2<br>• Other</td>
                    <td>None</td>
                    <td>0.1 mg/kg/hr</td>
                    <td>0.05 mg/kg/hr</td>
                    <td>60 min</td>
                    <td>0.4 mg/kg/hr</td>
                    <td class="dosing">0.05 - 0.4 mg/kg/hr</td>
                    <td class="comments">Goal parameter must be monitored and documented every 60 minutes until goal is met.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Labetalol -->
                <tr class="antihypertensive">
                    <td class="medication-name">Labetalol</td>
                    <td class="concentration">#1: 1 mg/mL<br>#2: 2 mg/mL</td>
                    <td class="dosing">#1: 200 mg/200 mL<br>#2: 200 mg/100 mL</td>
                    <td class="goal-param">• SBP 130-160<br>• SBP 140-180<br>• Other</td>
                    <td class="dosing">• 10 mg<br>• 20 mg<br>• Other</td>
                    <td>1 mg/min</td>
                    <td>0.5 mg/min</td>
                    <td>10 min</td>
                    <td>6 mg/min</td>
                    <td class="dosing">0.5 - 6 mg/min</td>
                    <td class="comments">Goal parameter must be monitored and documented every 10 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Lorazepam -->
                <tr class="sedative">
                    <td class="medication-name">Lorazepam</td>
                    <td class="concentration">#1: 1 mg/mL<br>#2: 2 mg/mL</td>
                    <td class="dosing">#1: 100 mg/100 mL<br>#2: 200 mg/100 mL</td>
                    <td class="goal-param">• RASS 0 to -2<br>• Other</td>
                    <td class="dosing">• 1 mg<br>• 2 mg<br>• Other</td>
                    <td>1 mg/hr</td>
                    <td>1 mg/hr</td>
                    <td>30 min</td>
                    <td>10 mg/hr</td>
                    <td class="dosing">1 - 10 mg/hr</td>
                    <td class="comments"><span class="warning">Warning: Medication causes respiratory depression.</span><br><br>Not appropriate alone if patient on neuromuscular blocker (NMB).<br><br>Goal parameter must be monitored and documented every 30 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Midazolam -->
                <tr class="sedative">
                    <td class="medication-name">Midazolam</td>
                    <td class="concentration">#1: 1 mg/mL<br>#2: 5 mg/mL</td>
                    <td class="dosing">#1: 100 mg/100 mL<br>50 mg/50 mL<br>#2: 250 mg/50 mL</td>
                    <td class="goal-param">• RASS 0 to -2<br>• RASS -4 to -5 if on NMB<br>• Other</td>
                    <td class="dosing">• 1 mg<br>• 2 mg<br>• Other</td>
                    <td>2 mg/hr</td>
                    <td>1 mg/hr</td>
                    <td>15 min</td>
                    <td>10 mg/hr</td>
                    <td class="dosing">1 - 10 mg/hr</td>
                    <td class="comments"><span class="warning">Warning: Medication causes respiratory depression.</span><br><br>Goal parameter must be monitored and documented every 15 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Milrinone -->
                <tr class="inotrope">
                    <td class="medication-name">Milrinone</td>
                    <td class="concentration">#1: 200 mcg/mL</td>
                    <td class="dosing">#1: 40 mg/200 mL<br>#2: 20 mg/100 mL</td>
                    <td class="goal-param">• MAP 65-75<br>• CI 2-4<br>• Other</td>
                    <td class="dosing">• 50 mcg/kg<br>• Other</td>
                    <td>0.25 mcg/kg/min</td>
                    <td>0.125 mcg/kg/min</td>
                    <td>15 min</td>
                    <td>0.75 mcg/kg/min</td>
                    <td class="dosing">0.125 - 0.75 mcg/kg/min</td>
                    <td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Morphine -->
                <tr class="analgesic">
                    <td class="medication-name">Morphine</td>
                    <td class="concentration">#1: 1 mg/mL</td>
                    <td class="dosing">#1: 100 mg/100 mL<br>#2: 50 mg/50 mL</td>
                    <td class="goal-param">• CPOT 0-2<br>• Other</td>
                    <td class="dosing">• 2 mg<br>• 4 mg<br>• Other</td>
                    <td>2 mg/hr</td>
                    <td>1 mg/hr</td>
                    <td>60 min</td>
                    <td>10 mg/hr</td>
                    <td class="dosing">1 - 10 mg/hr</td>
                    <td class="comments"><span class="warning">Warning: Medication causes respiratory depression.</span><br><br>For Breakthrough Pain (CPOT >2): Bolus 2 mg every 10 minutes up to 3 times within one hour. If goal is not achieved after 3 consecutive boluses, then increase infusion rate.<br><br>Goal parameter must be monitored and documented every 60 minutes until goal is met.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Nicardipine -->
                <tr class="antihypertensive">
                    <td class="medication-name">Nicardipine</td>
                    <td class="concentration">#1: 0.1 mg/mL<br>#2: 0.2 mg/mL</td>
                    <td class="dosing">#1: 25 mg/250 mL<br>#2: 50 mg/250 mL</td>
                    <td class="goal-param">• SBP 130-150<br>• SBP 130-160<br>• SBP 140-180<br>• SBP 150-180, DBP <105<br>• SBP 150-185, DBP <110<br>• SBP 160-200<br>• Other</td>
                    <td>None</td>
                    <td>5 mg/hr</td>
                    <td>2.5 mg/hr</td>
                    <td>5 min</td>
                    <td>15 mg/hr</td>
                    <td class="dosing">2.5 - 15 mg/hr</td>
                    <td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Nitroglycerin -->
                <tr class="antihypertensive">
                    <td class="medication-name">Nitroglycerin</td>
                    <td class="concentration">#1: 200 mcg/mL<br>#2: 400 mcg/mL</td>
                    <td class="dosing">#1: 50 mg/250 mL<br>#2: 100 mg/250 mL</td>
                    <td class="goal-param">• SBP 130-160<br>• SBP 140-180<br>• Chest pain relief<br>• Other</td>
                    <td>None</td>
                    <td>10 mcg/min</td>
                    <td>10 mcg/min</td>
                    <td>3 min</td>
                    <td>200 mcg/min</td>
                    <td class="dosing">5 - 200 mcg/min</td>
                    <td class="comments">Goal parameter must be monitored and documented every 3 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Nitroprusside -->
                <tr class="antihypertensive">
                    <td class="medication-name">Nitroprusside</td>
                    <td class="concentration">#1: 200 mcg/mL<br>#2: 400 mcg/mL</td>
                    <td class="dosing">#1: 50 mg/250 mL<br>#2: 100 mg/250 mL</td>
                    <td class="goal-param">• SBP 130-160<br>• SBP 140-180<br>• Other</td>
                    <td>None</td>
                    <td>0.3 mcg/kg/min</td>
                    <td>0.5 mcg/kg/min</td>
                    <td>2 min</td>
                    <td>10 mcg/kg/min</td>
                    <td class="dosing">0.3 - 10 mcg/kg/min</td>
                    <td class="comments">Protect from light.<br><br>Goal parameter must be monitored and documented every 2 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Norepinephrine -->
                <tr class="vasopressor">
                    <td class="medication-name">Norepinephrine</td>
                    <td class="concentration">#1: 16 mcg/mL<br>#2: 32 mcg/mL<br>#3: 64 mcg/mL</td>
                    <td class="dosing">#1: 4 mg/250 mL<br>#2: 8 mg/250 mL<br>#3: 16 mg/250 mL</td>
                    <td class="goal-param">• MAP 65-75<br>• Other</td>
                    <td>None</td>
                    <td>2 mcg/min</td>
                    <td>2 mcg/min</td>
                    <td>2 min</td>
                    <td>30 mcg/min</td>
                    <td class="dosing">1 - 30 mcg/min</td>
                    <td class="comments">Administration via peripheral line may be considered for up to 24 hours.<br><br>Rates greater than 15 mcg/min must be administered via a central line.<br><br>Goal parameter must be monitored and documented every 2 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Phenylephrine -->
                <tr class="vasopressor">
                    <td class="medication-name">Phenylephrine</td>
                    <td class="concentration">#1: 80 mcg/mL<br>#2: 400 mcg/mL</td>
                    <td class="dosing">#1: 20 mg/250 mL<br>#2: 100 mg/250 mL</td>
                    <td class="goal-param">• MAP 65-75<br>• Other</td>
                    <td>None</td>
                    <td>50 mcg/min</td>
                    <td>10 mcg/min</td>
                    <td>5 min</td>
                    <td>200 mcg/min</td>
                    <td class="dosing">10 - 200 mcg/min</td>
                    <td class="comments">Administration via peripheral line may be considered for up to 24 hours.<br><br>Rates greater than 150 mcg/min must be administered via a central line.<br><br>Goal parameter must be monitored and documented every 5 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Propofol -->
                <tr class="sedative">
                    <td class="medication-name">Propofol</td>
                    <td class="concentration">#1: 10 mg/mL</td>
                    <td class="dosing">#1: 1000 mg/100 mL<br>#2: 500 mg/50 mL</td>
                    <td class="goal-param">• RASS 0 to -2<br>• RASS -4 to -5 if on NMB<br>• Other</td>
                    <td class="dosing">• 10 mg<br>• 20 mg<br>• Other</td>
                    <td>10 mcg/kg/min</td>
                    <td>5 mcg/kg/min</td>
                    <td>5 min</td>
                    <td>60 mcg/kg/min</td>
                    <td class="dosing">5 - 60 mcg/kg/min</td>
                    <td class="comments">Change vial and tubing every 12 hours.<br><br>Check triglycerides at baseline and weekly. Consider more frequent TG level for high dose propofol.<br><br>Goal parameter must be monitored and documented every 5 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Rocuronium -->
                <tr class="neuromuscular-blocker high-alert">
                    <td class="medication-name">Rocuronium<br><span class="warning">**HIGH ALERT**</span></td>
                    <td class="concentration">#1: 1 mg/mL<br>#2: 10 mg/mL</td>
                    <td class="dosing">#1: 100 mg/100 mL<br>#2: 300 mg/30 mL</td>
                    <td class="goal-param">• TOF 2/4<br>• Ventilator synchrony<br>• Other</td>
                    <td class="dosing">• 1 mg/kg<br>• Other</td>
                    <td>5 mcg/kg/min</td>
                    <td>1 mcg/kg/min</td>
                    <td>15 min</td>
                    <td>16 mcg/kg/min</td>
                    <td class="dosing">1 - 16 mcg/kg/min</td>
                    <td class="comments"><span class="warning">Warning: Paralyzing agent causes respiratory depression.</span> Patient must be ventilated and sedated prior to administration with RASS goal -4. Do not titrate sedation off while on paralytic.<br><br>Obtain baseline train-of-four prior to beginning infusion.<br><br>Goal parameter must be monitored and documented every 15 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
                
                <!-- Vecuronium -->
                <tr class="neuromuscular-blocker high-alert">
                    <td class="medication-name">Vecuronium<br><span class="warning">**HIGH ALERT**</span></td>
                    <td class="concentration">#1: 1 mg/mL</td>
                    <td class="dosing">#1: 100 mg/100 mL</td>
                    <td class="goal-param">• TOF 2/4<br>• Ventilator synchrony<br>• Other</td>
                    <td class="dosing">• 0.1 mg/kg<br>• Other</td>
                    <td>1 mcg/kg/min</td>
                    <td>0.1 mcg/kg/min</td>
                    <td>15 min</td>
                    <td>1.7 mcg/kg/min</td>
                    <td class="dosing">0.1 - 1.7 mcg/kg/min</td>
                    <td class="comments"><span class="warning">Warning: Paralyzing agent causes respiratory depression.</span> Patient must be ventilated and sedated prior to administration with RASS goal -4. Do not titrate sedation off while on paralytic.<br><br>Obtain baseline train-of-four prior to beginning infusion.<br><br>Goal parameter must be monitored and documented every 15 minutes until goal is met. Once goal is met, RN may document goal every 30-60 minutes.<br><br>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br><br>Discontinue order if rate remains at zero for 23 hours.<br><br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
                </tr>
            </tbody>
        </table>
    </div>
    
    <div class="footer">
        <strong>Adventist Health</strong> | Medication Safety Standards<br>
        For internal use only | Updated: November 2025
    </div>
</body>
</html>
